Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2015 | 09-2014 | 09-2013 | 09-2012 | 09-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81,214 | 132,511 | 19,114 | 3,377 | 7,507 |
| Marketable Securities | 17,540 | 21,653 | 9,030 | 107 | 635 |
| Receivables | N/A | N/A | 75 | 19 | 1,608 |
| Other current assets | 824 | 49 | 92 | 2,446 | 0 |
| TOTAL | $102,871 | $154,801 | $28,844 | $6,567 | $9,861 |
| Non-Current Assets | |||||
| PPE Net | 4,527 | 3,873 | 3,513 | 4,896 | 25 |
| Investments And Advances | 0 | 23,088 | 1,702 | 0 | 1,837 |
| Intangibles | 24,824 | 1,014 | 3,241 | 4,785 | 1,731 |
| Other Non-Current Assets | 46 | 41 | 30 | 280 | 2,434 |
| TOTAL | $29,397 | $28,016 | $8,486 | $9,961 | $6,027 |
| Total Assets | $132,268 | $182,817 | $37,330 | $16,528 | $15,889 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,032 | 2,580 | 1,200 | 878 | 577 |
| Accrued Expenses | 9,200 | 4,668 | 1,545 | 1,858 | 1,060 |
| Other current liabilities | 1,348 | 4,232 | 4,685 | 2,240 | 945 |
| TOTAL | $15,901 | $11,847 | $8,725 | $5,328 | $2,582 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | N/A | 50 | 839 | 607 |
| Deferred Revenues | 103 | 103 | 103 | 38 | 0 |
| Other Non-Current Liabilities | 6,062 | 4,321 | 2,319 | 1,254 | 499 |
| TOTAL | $6,746 | $4,985 | $2,870 | $2,391 | $742 |
| Total Liabilities | $22,646 | $16,832 | $11,595 | $7,719 | $3,324 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,555 | 54,683 | 38,700 | 15,644 | 10,526 |
| Common Shares | 152 | 147 | 125 | 108 | 86 |
| Retained earnings | -316,712 | -224,771 | -166,141 | -134,998 | -113,872 |
| Other shareholders' equity | -692 | -555 | -1,764 | -2,220 | -1,127 |
| TOTAL | $109,622 | $165,985 | $25,735 | $8,809 | $12,564 |
| Total Liabilities And Equity | $132,268 | $182,817 | $37,330 | $16,528 | $15,889 |